Abstract

The A2A and A2B adenosine receptors (A2AR and A2BR) are implicated in many physiological processes. However, the mechanisms of their intracellular maturation and trafficking are poorly understood. In comparative studies of A2AR versus A2BR expression in transfected cells, we noticed that the levels of cell surface expression of A2BR were significantly lower than those of A2AR. A large portion of the A2BR was degraded by the proteasome. Studies of cell surface expression of A2BR chimeric molecules in transfectants suggested that A2BR does not have the dominant forward transport signal for export from the endoplasmic reticulum to the cell surface. A2BR surface expression was increased in A2BR chimeras where the A2BR carboxyl terminus (CT) was replaced or fused with the A2AR CT. Co-transfection of A2AR with A2BR enhanced surface expression of A2BR though the F(X)(6)LL motif in the A2AR CT. The requirements of A2AR expression for better A2BR cell surface expression was not only established in transfectants but also confirmed by observations of much lower levels of A2BR-induced intracellular cAMP accumulation in response to A2BR-activating ligand in splenocytes from A2AR(-/-) mice than in wild type mice. The results of mechanistic studies suggested that poor A2BR expression at the cell surface might be accounted for mainly by the lack of a dominant forward transport signal from the endoplasmic reticulum to the plasma membrane; it is likely that A2BR forms a hetero-oligomer complex for better function.

Highlights

  • Health Grant R01 CA111985 and R01 CA112561

  • The total protein expression levels of A2BR and A2AR were studied by immunoprecipitation followed by immunoblotting, whereas cell surface expression was determined by enzyme-linked immunoassay as described [34]

  • We were not able to further increase cell surface expression of A2BR by increasing the amount of DNA used for transfection, because it always resulted in even lower A2BR expression than when using 2 ␮g of DNA, as judged by immunoprecipitation followed by immunoblotting

Read more

Summary

EXPERIMENTAL PROCEDURES

MG132 was purchased from EMD Chemicals (San Diego, CA). Lactacystin, A2AR-selective agonist CGS21680, and nonselective agonist 5-N-ethyl-carboxamidoadenosine (NECA) were purchased from Tocris (Ellisville, MO). Construction of Tagged A2AR, A2BR, and ␤2AR—A triple HA or triple Myc tag was introduced by a two-step PCR procedure [31] into the XhoI-EcoRI sites of pCI-neo vector (Promega). Underlining of the sense and antisense primers for both A2AR and A2BR represents the EcoRI and NotI sites, respectively. To replace the region encoding the CT of the ␤2AR with A2BR, the BamHI site was introduced to ␤2AR cDNA at position 344, and the BamHI-NotI fragment of ␤2AR was replaced to create pCI-neoHA-A2B-␤2CT. The human embryonic kidney cell line, AD-293 cells (Stratagene, La Jolla, CA), was transfected with either HA-, Myc-, or FLAG-tagged adenosine receptors or HA- or FLAG-tagged ␤2AR constructs using the FuGENE 6 reagent (Roche Applied Science). The cells surviving selection were sorted by immunofluorescence for adenosine receptor expression and subsequently maintained in G418

Biochemical Procedures
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call